CA2566804A1 - Utilisation de lipopolysaccharide dans un condensat de respiration exhalee aux fins de diagnostic de la pneumonie a gram negatif - Google Patents

Utilisation de lipopolysaccharide dans un condensat de respiration exhalee aux fins de diagnostic de la pneumonie a gram negatif Download PDF

Info

Publication number
CA2566804A1
CA2566804A1 CA002566804A CA2566804A CA2566804A1 CA 2566804 A1 CA2566804 A1 CA 2566804A1 CA 002566804 A CA002566804 A CA 002566804A CA 2566804 A CA2566804 A CA 2566804A CA 2566804 A1 CA2566804 A1 CA 2566804A1
Authority
CA
Canada
Prior art keywords
breath condensate
exhaled breath
lipopolysaccharide
reaction chamber
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002566804A
Other languages
English (en)
Inventor
Jeffrey A. Kline
Jackeline Hernandez
John Albert Watts, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charlotte Mecklenburg Hospital
Original Assignee
The Charlotte-Mecklenburg Hospital Authority
Jeffrey A. Kline
Jackeline Hernandez
John Albert Watts, Jr.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Charlotte-Mecklenburg Hospital Authority, Jeffrey A. Kline, Jackeline Hernandez, John Albert Watts, Jr. filed Critical The Charlotte-Mecklenburg Hospital Authority
Publication of CA2566804A1 publication Critical patent/CA2566804A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0813—Measurement of pulmonary parameters by tracers, e.g. radioactive tracers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
CA002566804A 2004-06-07 2005-05-24 Utilisation de lipopolysaccharide dans un condensat de respiration exhalee aux fins de diagnostic de la pneumonie a gram negatif Abandoned CA2566804A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57764104P 2004-06-07 2004-06-07
US60/577,641 2004-06-07
PCT/US2005/018232 WO2006007180A2 (fr) 2004-06-07 2005-05-24 Utilisation de lipopolysaccharide dans un condensat de respiration exhalee aux fins de diagnostic de la pneumonie a gram negatif

Publications (1)

Publication Number Publication Date
CA2566804A1 true CA2566804A1 (fr) 2006-01-19

Family

ID=35784291

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002566804A Abandoned CA2566804A1 (fr) 2004-06-07 2005-05-24 Utilisation de lipopolysaccharide dans un condensat de respiration exhalee aux fins de diagnostic de la pneumonie a gram negatif

Country Status (8)

Country Link
EP (1) EP1761166A4 (fr)
JP (2) JP4804464B2 (fr)
AU (1) AU2005262701B2 (fr)
BR (1) BRPI0511846A (fr)
CA (1) CA2566804A1 (fr)
IL (5) IL179137A (fr)
MX (1) MXPA06014248A (fr)
WO (1) WO2006007180A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7828741B2 (en) 2002-12-20 2010-11-09 The Charlotte-Mecklenburg Hospital Authority Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
AU2003300356A1 (en) 2002-12-20 2004-07-22 The Charlotte-Mecklenburg Hospital Authority Disposable hand-held device for collection of exhaled breath condensate
WO2004073497A2 (fr) 2003-02-14 2004-09-02 The Charlotte-Mecklenburg Hospital Authority Dispositif et procede de collecte de condensat d'exhalation alveolaire
EP2194867B1 (fr) * 2007-10-02 2021-06-02 Anna-Carin Olin Récupération et mesure de particules exhalées
EP2281199B1 (fr) * 2008-06-04 2017-03-01 KCI Licensing, Inc. Détection d'infection dans le traitement de plaie à pression réduite
GB201312635D0 (en) * 2013-07-15 2013-08-28 Univ Plymouth Water testing
US10413216B2 (en) * 2016-02-03 2019-09-17 Quintron Instrument Company, Inc. Breath testing apparatus
CN106018362B (zh) * 2016-05-16 2018-06-08 江苏国恒检测有限公司 一种检测苦味酸的测定器
JP7188823B2 (ja) * 2018-09-06 2022-12-13 杭州優思達生物技術有限公司 試料容器
CN117883121A (zh) 2019-08-26 2024-04-16 泽特奥科技公司 利用呼出气诊断结核病和其他疾病
WO2023038582A2 (fr) * 2021-09-10 2023-03-16 National University Of Singapore Kit de prélèvement de condensat d'air expiré

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59383A (en) * 1980-02-14 1983-03-31 Technion Res & Dev Foundation Micromethod for the determination of endotoxins with limulus amebocyte lysate
US4349626A (en) * 1980-10-28 1982-09-14 The Monell Chemical Senses Center Method of detecting Pseudomonas aeruginosa infections utilizing selected ketone and/or sulfur metabolites
US5541057A (en) * 1989-09-18 1996-07-30 Biostar, Inc. Methods for detection of an analyte
SE9704329D0 (sv) * 1997-11-25 1997-11-25 Siemens Elema Ab Gasmätare
AU776296B2 (en) * 1998-12-18 2004-09-02 University Of Virginia Patent Foundation Device and method for monitoring asthma
EP1169640B1 (fr) * 1999-03-09 2005-06-15 Osmetech PLC Procede pour detecter des desordres en analysant le condensat des gaz respiratoires
WO2001084112A1 (fr) * 2000-05-01 2001-11-08 Respiratory Research, Inc. Procede et dispositif pour recueillir et analyser de l'air exhale
US20040234971A1 (en) * 2001-02-01 2004-11-25 Joany Jackman Diagnosis of pathogen infections using mass spectral analysis of immune system modulators in post-exposure biological samples

Also Published As

Publication number Publication date
JP2008501976A (ja) 2008-01-24
JP4804464B2 (ja) 2011-11-02
EP1761166A4 (fr) 2009-11-11
IL179137A (en) 2012-07-31
IL218189A0 (en) 2012-04-30
WO2006007180A2 (fr) 2006-01-19
BRPI0511846A (pt) 2008-01-15
MXPA06014248A (es) 2007-06-25
AU2005262701B2 (en) 2011-12-01
IL179137A0 (en) 2007-03-08
IL218188A0 (en) 2012-04-30
EP1761166A2 (fr) 2007-03-14
IL218190A0 (en) 2012-04-30
IL218191A0 (en) 2012-04-30
WO2006007180A3 (fr) 2006-11-30
JP2009186487A (ja) 2009-08-20
AU2005262701A1 (en) 2006-01-19
JP4852121B2 (ja) 2012-01-11

Similar Documents

Publication Publication Date Title
US7828741B2 (en) Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
AU2005262701B2 (en) Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
Garay et al. A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients
O'Grady et al. Practice guidelines for evaluating new fever in critically ill adult patients
Karalus et al. Community acquired pneumonia: aetiology and prognostic index evaluation.
Slovis et al. Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection
US20130190639A1 (en) Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
Smith What diagnostic tests are needed for community-acquired pneumonia?
Baughman The uncertainties of bronchoalveolar lavage
Tobin Diagnosis of pneumonia: techniques and problems
Rodrguez de Castro et al. Quantitative cultures of protected brush specimens and bronchoalveolar lavage in ventilated patients without suspected pneumonia.
AU2012201120A1 (en) Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
Grattan-Smith et al. Viral supraglottitis
Zhaoming et al. A review of allergic bronchopulmonary aspergillosis
JP4711846B2 (ja) 甚急性乳房炎の判定方法
Ku et al. Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis
Brearley et al. Endotoxin levels in portal and systemic blood
Robert et al. Helicobacter pylori infection is not associated with an increased hemorrhagic risk in patients in the intensive care unit
Kandi Diagnosis of community acquired pneumonia
Dennesen et al. The development of ventilator-associated pneumonia does not change aspects of mechanical ventilation
Abdullaev et al. ETIOLOGICAL, DIAGNOSTIC AND MORPHOLOGICAL FEATURES OF SEVERE PNEUMONIA (LITERATURE REVIEW)
RU2324191C2 (ru) Способ диагностики дисбактериоза кишечника
Wright et al. Pyogenic liver abscess
Torres et al. Diagnosis and classification of Pneumonia
Vanprapar et al. Cerebrospinal fluid lactate level in childhood purulent meningitis.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued